Jocelyne Chapman

7PUBLICATIONS
70CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 13, 2026
Efficacy of the ATR Inhibitor Ceralasertib in Patients with ARID1A-Deficient Gynecologic and Other Solid Tumor Malignancies.

Xiaolin Zhu, Edwin A Alvarez, Sarah E Umetsu

|Aug 21, 2025
Leveraging sequences missing from the human genome to diagnose cancer.

Ilias Georgakopoulos-Soares, Ofer Yizhar-Barnea, Ioannis Mouratidis

|Jul 02, 2025
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity.

Tianyi Liu, Meng Zhang, Tatyanah Farsh

|Jun 12, 2024
Synthetic Lethality Beyond BRCA: A Phase I Study of Rucaparib and Irinotecan in Metastatic Solid Tumors With Homologous Recombination-Deficiency Mutations Beyond BRCA1/2.

Erica S Tsang, Mallika S Dhawan, Romain Pacaud

|Jan 13, 2022
Validation of Anticorrelated TGFβ Signaling and Alternative End-Joining DNA Repair Signatures that Predict Response to Genotoxic Cancer Therapy.

Ines Guix, Qi Liu, Miquel Angel Pujana

|Aug 26, 2021
Primary treatment of advanced ovarian cancer: how does the 'real world' practice?

Amaranta D Craig, Eduardo Garcia, Pamela N Peters

Pageof 2

Frequent Collaborators

2 joint publications

Xiaolin Zhu

2 joint publications

Stefanie Ueda

2 joint publications

Lee-May Chen

2 joint publications

Felix Y Feng